BT-7480

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameBT-7480
Drug Alias NameBT-7480BCY-11863BCY-00011863
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionCytotoxic T lymphocytes stimulantsTumor necrosis factor receptor superfamily member 9 agonistsNectin-4 modulators
TargetsTumor necrosis factor receptor superfamily member 9Nectin-4
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBicycle Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesBicycle Tx LtdBicycle Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A